Business Wire

Lineage Foundation for Good Celebrates One-Year Anniversary, Announces “Holidays for Good” Campaign

16.11.2022 16:00:00 EET | Business Wire | Press release

Share

Lineage Foundation for Good (the “Foundation”), the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”), recently celebrated its one-year anniversary. The nonprofit, which aims to redirect food that would otherwise go to waste and address hunger to support the social and economic mobility of our communities, has successfully donated the equivalent of 239 million meals over the past two years.

“Given recent events, global hunger and food insecurity is rising, affecting more than 800 million people,” said Christine Rees-Zecha, Board President of the Lineage Foundation for Good. “Through the Lineage Foundation for Good, we aim to leverage our network, expertise, and partnerships to prevent waste and redirect food into the communities that need it most. While there is still more work to do, I am proud of the accomplishments we achieved in the first year, including delivering more than 200 million meals to those in need, made possible by our dedicated team members.”

Last October, Lineage launched the Lineage Foundation for Good following the Company’s successful inaugural campaign, which provided 100 million meals to people in need during the height of the pandemic. In addition to supporting Lineage’s philanthropic efforts, the Foundation has sought to strengthen initiatives and organizations that align with the Company’s mission to create innovative and sustainable solutions to help reduce food waste and fight food insecurity.

At its inception, the Foundation set a goal to donate the equivalent of 500 million meals to people in need by 2025. To date, it is on track to significantly exceed this goal. As the Foundation continues to make progress on this commitment, it has also achieved notable progress in the following areas:

  • Raised over $234,000 to support the Global FoodBanking Network and the Polish Humanitarian Action Organization’s efforts in response to the ongoing conflict in Ukraine.
  • Supported Lineage team members and their families impacted by the conflict who returned to Ukraine to assist by continuing to pay their wages, as well as providing stipends to team members who are housing refugees and covered the relocation costs of five families.
  • Contributed over 1,000 volunteer hours in communities worldwide, such as volunteering at food banks and distributing meals at community-based kitchens.
  • Issued more than $1.6 million in community-based grants to local food banks, schools and other community-based organizations to help with operational costs.
  • Donated over $600,000 to the Team Member Hardship Grant program, an initiative dedicated to financially supporting Lineage team members through times of hardship.
  • In partnership with Penske, Darden Foundation, supported the donation of 10 refrigerated trucks to Feeding America® member food banks.
  • Received a historic one-million-pound donation that will benefit six food banks within the Feeding America network.
  • Grew its global network of partnerships to 50 strategic partners, which includes the Global FoodBanking Network, Feeding America, Empowerment Plan, Move for Hunger and the Darden Foundation. Through these partnerships, the Foundation has coordinated volunteer events and made charitable donations to partners.

“Over the past year, we’ve partnered with the Lineage Foundation for Good on their mission to reduce food waste and address food insecurity,” said Diane Letson, vice president of food industry partnerships at Feeding America. “With nearly 34 million people facing hunger in America, and amid the challenging inflationary environment many are experiencing, we are grateful for the recent work that Lineage and its partners accomplished in diverting one million pounds of food from going to waste and ensuring that it reached our neighbors in need.”

Building on the momentum of a successful first year, the Foundation is also launching the “Holidays for Good” Campaign to donate food to local communities during the holiday season. Beginning in November and running through the holiday season, “Holidays for Good” will contribute the equivalent of one million meals through customer product donations, food drives and volunteer events that benefit local community food banks.

For more information on the Lineage Foundation for Good, visit the Foundation page here. You can also reach out to foundation@lineagelogistics.com for information on partnership opportunities, volunteer events, and other ways to support.

About Lineage Foundation for Good

The Lineage Foundation for Good (the “Foundation”) is the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”). The Foundation leverages the unique access, influence, experience, and expertise of Lineage, one of the world’s largest temperature-controlled logistics solutions providers, and its customers and partners to reduce food waste and fight food insecurity – a need that was accelerated by the practical challenges of getting quality food to those in need during the COVID-19 pandemic. Central to the Foundation’s mission is to develop a dynamic, real-time, and global link between those who commercially produce our food and the individuals, families, and communities who need it most. The Foundation creates a system in which food products, including those that might have otherwise gone to waste, can be quickly and easily steered to food pantries and other non-profits combatting food insecurity around the world. The Foundation supports various philanthropic initiatives that have an impact in the communities in which we live and work, and is proud to partner with Feeding America, the Global FoodBanking Network, and other organizations to expand its reach, maximize its impact, and help feed the world.

About Lineage Logistics

Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity, which spans 20 countries across North America, Europe, and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network and the development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was a 2022 U.S. Best Managed Company, No. 3 in the 2022 CNBC Disruptor 50 list, No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com)

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Lineage Logistics
Christina Wiese
734-608-1855
cwiese@lineagelogistics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye